Power of biomarkers and their relative contributions to metabolic syndrome in Slovak adult women

Annals of Human Biology

Volumn 40, Issue 2, 2013, Pages 132-138

  Luptáková, Lenka ^a   Siváková, Daniela ^a   Cvíčelová, Marta ^a   Wsólová, Ladislava ^b   Danková, Zuzana ^a   Michnová, Alexandra ^a   Blažíček, Pavel ^c  

^a Faculty of Natural Sciences   (Slovakia)

^b Research Base of the Slovak Medical University   (Slovakia)

^c Alpha Medical ^*  (Slovakia)

Author keywords

ACE genotypes; APOE genotypes; Biochemical parameters; Metabolic syndrome

Indexed keywords

ACE PROTEIN, HUMAN; APOLIPOPROTEIN E; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE;

BIOCHEMISTRY; BIOMARKER; CARDIOVASCULAR DISEASE; DISEASE INCIDENCE; ENZYME ACTIVITY; GENE EXPRESSION; GENOTYPE; HEALTH RISK; MORTALITY; PLASMA; REGRESSION ANALYSIS; RISK FACTOR; WOMENS HEALTH;

ADULT; AGED; ARTICLE; BLOOD; BLOOD ANALYSIS; BODY MASS; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; HYPERTENSION; INCIDENCE; LIVER; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; PREVALENCE; RISK FACTOR; SLOVAKIA; VERY ELDERLY; WAIST HIP RATIO;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; BODY MASS INDEX; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; LIVER; METABOLIC SYNDROME X; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; PREVALENCE; RISK FACTORS; SLOVAKIA; WAIST-HIP RATIO;

SLOVAKIA;

EID: 84875740957     PISSN: 03014460     EISSN: 14645033     Source Type: Journal    
DOI: 10.3109/03014460.2012.748828     Document Type: Article

References (46)

1. Alberti MK, Zimmet P, Shaw J. 2006. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23:469-480.
2. Alvarez-Aguilar C, Enriquez-Ramirez ML, Figueroa-Nunez B, Gómez-García A, Rodríguez-Ayala E, Morán-Moguel C, Farías-Rodríguez VM, Mino-León D, López-Meza JE. 2007. Association between angiotensin-1 converting enzyme gene polymorphism and the metabolic syndrome in a Mexican population. Exp Mol Med 39: 327-334.
3. Costa LA, Canani LH, Maia AL, Gross JL. 2002. The ACE insertion/deletion polymorphism is not associated with the metabolic syndrome (WHO Definition) in Brazilian type 2 diabetic patients. Diabetes Care 25:2365-2366.
4. Crews ED, Williams LS. 1999. Molecular aspects of blood pressure. Hum Biol 71:475-503.
5. Danková Z, Siváková D, Luptáková L, Blazícek P. 2009. Association of ACE (I/D) polamorphism with metabolic syndrome and hypertension in two ethnic groups in Slovakia. Anthrop Anz 67:305-316.
6. Das M, Pal S, Ghosh A. 2009. Synergistic effects of ACE (I/D) and ApoE (HhaI) gene polymorphisms among the adult Asian Indians with and without metabolic syndrome. Diabetes Res Clin Pract 86: 58-61.
7. Deka R, Durakovic Z, Niu W, Zhang G, Karns R, Smolej-Narancic N, Missoni S, Caric D, Caric T, Rudan D, Salzer B, Chakraborty R, Rudan P. 2012. Prevalence of metabolic syndrome and related metabolic traits in an island population of the Adriatic. Ann Hum Biol 39:46-53.
8. Dekker MJ, Girman C, Rhodes T, Nijpels G, Stehouwer C, Bouter L, Heine R. 2005. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 112:666-673.
9. Eckel RH, Grundy SM, Zimmet PZ. 2005. The metabolic syndrome. Lancet 365:1415-1128.
10. Eshtiaghi R, Esteghamati A, Nakhjavani M. 2010. Menopause is an independent predictor of metabolic syndrome in Iranian women. Maturitas 65:262-266.
11. Fiatal S, Szigethy E, Széles G, Tóth R, Adány R. 2011. Insertion/deletion polymorphism of angiotensin-1 converting enzyme is associated with metabolic syndrome in Hungarian adults. J of Renin Angiotensin Aldosterone 12:531-538.
12. Friedewald WT, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502.
13. Goldbourt U, Medalie JH, Herman JB, Neufeld H. 1980. Serum uric acid: correlation with biochemical, anthropometric, clinical and behavioral parameters in 10, 000 Israeli men. J Chronic Dis 33: 435-443.
14. Grundy MS, Cleeman IJ, Daniels RS, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Jr, Spertus JA, Costa F. 2005. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735-2752.
15. Hixson JE, Vernier TD. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Research 31:545-548.
16. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K. 2004. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 164:1066-1076.
17. Iglseder B, Cip P, Malaimare L, Ladurner G, Paulweber B. 2005. The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Stroke 36:1212-1217.
18. Kaczmarek M. 2007. The timing of natural menopause in Poland and associated factors. Maturitas 57:139-153.
19. Kolovou GD, Anagnostopoulou KK. 2007. Apolipoprotein E polymorphism, age and coronary heart disease. Ageing Res Rev 6: 94-108.
20. Lee GJ, Lee S, Kim JY, Jin KH, Cho MB, Kim JY, Jeong WD, Park JH, Kim UJ. 2009. Multiple biomarkers and their relative contributions to identifying metabolic syndrome. Clin Chim Acta 408:50-55.
21. Lee YJ, Tsai JC. 2002. ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 25:1002-1008.
22. Lin S, Tsai D, Hsu S. 2006. Association between serum uric acid level and components of the metabolic syndrome. J Chin Med Assoc 69: 512-516.
23. LinksHajer GR, van der Graaf Y, Olijhoek JK, Verhaar MC, Visseren FL. 2007. SMART Study Group. Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome. Heart 93:216-220.
24. Liu WP, Chang YT, Chen DJ. 2010. Serum uric acid and metabolic syndrome in Taiwanese adults. Metabol Clin Exp 59:802-807.
25. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough A, Natale S, Forlani G, Melchionda N. 2001. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50:1844-1844.
26. Milionis HJ, Kostapanos MS, Vakalis K, Theodorou I, Bouba I, Kalaitzidis R, Georgiou I, Elisaf SM, Siamopouloset CK. 2007. Impact of renin-angiotensin- aldosterone system genes on the treatment response of patients with hypertension and metabolic syndrome. J Renin Angiotensin Aldosterone Syst 8:181-189.
27. NCEP ATP III-Expert Panel on Detection. Evaluation, and Treatment of High Blood Cholesterol in Adult 2001. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497.
28. NHLBI Obesity Education Initiative Expert Panel. 2000. The practical guide: Identification, evaluation, and treatment of overweight and obesity in adults. Bethesda, Md: National Institutes of Health, National Heart, Lung, and Blood Institute, North American Association for the Study of Obesity; USA, NIH Publication No. 00-4084. p 80.
29. Olivieri O, Martinelli N, Bassi A, Trabetti E, Girelli D, Pizzolo F, Friso S, Pignatti FP, Corrocher R. 2007. ApoE e2/e3/e4 polymorphism, ApoC-III/ApoE ratio and metabolic syndrome. Clin Exp Med 7: 164-172.
30. Onat A, Uyarel H, Hergenç G, Karabulut A, Albayrak S, Sari I, Yazici M, Keleşet I. 2006. Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens 19: 1055-1062.
31. Pitsavos Ch, Panagiotakos BD, Skoumas J, Papadimitriou L, Stefanadis CH. 2008. Risk stratification of apolipoprotein B, apolipoprotein A1, and apolipoprotein B/AI ratio on the prevalence of the metabolic syndrome: the ATTICA Study. Angiology 59: 225-341.
32. Rigat B, Hubert C, Corvol P, Soubrier F. 1992. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP 1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1420:33.
33. Saito T, Nishise Y, Makino N, Haga H, Ishii R, Okumoto K, Ito J, Watanabe H, Saito K, Takeda H, Togashi H, Kubota I, Daimon M, Kato T, Kawata S. 2009. Impact of metabolic syndrome on elevated serum alanine aminotransferase levels in the Japanese population. Metab Clin Exp 58:1067-1075.
34. Sima A, Iordan A, Stancu C. 2007. Apolipoprotein E polymorphism-a risk factor for metabolic syndrome. Clin Chem Lab Med 45: 1149-1153.
35. Siváková D, Zacharová M, Gasparovic J, Raslová K, Wsólová L, Basistová Z, Blazícek P. 2006. Apolipoprotein E polymorphism in relation to plasma lipid levels and other risk factors of atherosclerosis in two ethnic groups from Slovakia. Coll Antropol 2: 387-394.
36. Steer P, Hulthe J, Millgard J, Sarabi MD, Basu S, Vessby B, Linda L. 2002. Endothelial vasodilatory function is predicted by circulating apolipoprotein B and HDL in healthy humans. Lipids 37: 1135-1140.
37. Suh S, Choi S, Ahn H, Yang H, Kim Y, Sung N. 2009. The association between normal alanine aminotransferase levels and the metabolic syndrome: 2005 Korean National Health and Nutrition Examination Survey. Metab Clin Exp 58:1731-1736.
38. Sui X, Church ST, Meriwether AR, Lobelo F, Blair NS. 2008. Uric acid and development of metabolic syndrome in women and men. Metabol Clin Exp 57:845-852.
39. Szigethy E, Voko Z, Jermendy G, Nádas J, Paragh G, Blaskó G, Kardos L, Hidvégi T, Horváth A, Adány R, Széles G. 2007. The epidemiology of metabolic syndrome in the Hungarian adult population. Diab Vasc Dis Res Suppl 1:S94.
40. Tao HM, Liu WJ, LaMonte JM, Liu J, Wang L, He Y, Li YX, Wang NL, Ye L. 2011. Different associations of apolipoprotein E polymorphism with metabolic syndrome by sex in an elderly Chinese population. Metab Clin Exp 60:1488-1496.
41. Thomas GN, Tomlinson B, Chan JC, Sanderson JE, Cockram CS, Critchley JA. 2001. Renin-angiotensin system gene polymorphisms, blood pressure, dyslipidemia, and diabetes in Hong Kong Chinese: a significant association of tne ACE insertion/deletion polymorphism with type 2 diabetes. Diabetes Care 24:356-361.
42. Walldius G, Junger I. 2004. Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy. J Int Med 255:188-205.
43. WHO. 1996. Research on the Menopause in the 1990s. Report of a WHO Scientific Group. WHO Technical Report Series. No. 866. Geneva: World Health Organization (WHO).
44. WHO. 2008. Waist circumference and waist-hip ratio: report of a WHO expert consultation. Geneva: World Health Organization (WHO).
45. Yano K, Rhoads G, Kagan A. 1977. Epidemiology of serum uric acid among 8000 Japanese-American men in Hawaii. J Chronic Dis 30: 171-184.
46. Zajc-Petranović M, Skarić-Jurić T, Smolej-Narancić N, Tomas Z, Krajacić P, Milicić J, Barbalić M, Tomek-Roksandić S. 2012. Angiotensin-converting enzyme deletion allele is beneficial for the longevity for Europeans. Age 34:583-595.